Coprocessed Excipients: A Novel Method in the Pharmaceutical Sector

In recent years drug formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain active pharmaceutical ingredients to be formulated or manufactured adequately. In addition to this the cost involved in development of new chemical excipients with improved properties is quite high. In response to these deficiencies, drug formulation scientists have relied on increasing numbers of combination excipients introduced by excipient manufacturers into the commercial market. In order to justify the high rise in new drug development and high industrial output demand, new excipients with purpose satisfying characteristics are the need of the hour. New combinations of existing excipients are an interesting option for improving excipient functionality now-a-days. The future scope determines that coprocessed excipients are the rising need of 21st century.